SPR Supreme Resources Ltd.

SUPREME RESOURCES LTD. ("Supreme" or the "Corporation") (TSX VENTURE:SPR)
announces that it will, subject to regulatory approval, change its name to
Supreme Pharmaceuticals Inc. in conjunction with its recent decision to pursue
interests in pharmaceuticals or biomedical devices. 


David Stadnyk, President, stated "The current management team of the Corporation
has had highly successful experiences with finding and developing early stage
pharmaceutical or biomedical devices, so given the moribund junior mining
sector, we feel that if we can supply an additional line of business for
Supreme, shareholders will benefit. Some of the pharmaceutical and biomedical
companies that management has co-founded include Pharmaxis Ltd., Eupraxia
Pharmaceuticals Inc. (of which Mr. Tsafalas is currently a financial executive),
and Praxis Pharmaceuticals. We have no plans to dispose of or shelve our mineral
exploration properties, and will continue to work on them as the opportunities
present themselves. In the meantime, we are evaluating several significant
opportunities to advance on in the pharma field." 


About Supreme Resources Ltd.:

Supreme Resources Ltd. is a junior exploration company with advanced base and
precious metals projects located in producing mining districts of British
Columbia, Canada. Supreme Resources' goal is to increase shareholder value by
developing exploration projects that have the potential of becoming new
discoveries. 


Website: www.supremeresourcesltd.com 

Further news will be forthcoming in the near future. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. 


Statements in this press release other than purely historical factual
information, including statements relating to revenues or profits, or the
Company's future plans and objectives, or expected sales, cash flows, and
capital expenditures constitute forward-looking statements. Forward-looking
statements are based on numerous assumptions and are subject to all of the risks
and uncertainties inherent in the Company's business, including risks inherent
in the technology history. There can be no assurance that such forward-looking
statements will prove to be accurate, as actual results and future events could
differ materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on such statements. Except in accordance
with applicable securities laws, the Company expressly disclaims any obligation
to update any forward-looking statements or forward-looking statements that are
incorporated by reference herein. This news release does not constitute an offer
to sell, or a solicitation of an offer to buy any of the Company's securities
set out herein in the United States, or to, or for the benefit or account of, a
U.S. Person or person in the United States.


FOR FURTHER INFORMATION PLEASE CONTACT: 
David Stadnyk
President
604.428.0511
info@supremepharmaceuticals.com

Supreme Resources Ltd. (TSXV:SPR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Supreme Resources Ltd. (TSXV:SPR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024